Magdalena Kusaczuk Selected Research

naphtho(1,2-d)thiazol-2-ylamine

8/2019

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of KCa2.x and KCa3.1 Channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Kusaczuk Research Topics

Disease

12	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2016
9	Neoplasms (Cancer) 01/2022 - 01/2015
3	Hypertension (High Blood Pressure) 10/2021 - 08/2019
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2018
2	Obesity 01/2022 - 11/2019
2	Inflammation (Inflammations) 11/2019 - 01/2015
1	Adenocarcinoma 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Morbid Obesity 01/2022
1	Hypertrophy 10/2021
1	Necrosis 03/2021
1	Hypoxia (Hypoxemia) 02/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Overweight 01/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019
1	Digestive System Diseases 11/2019
1	Bradycardia 08/2019
1	Hypotension (Low Blood Pressure) 08/2019
1	Essential Hypertension 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2022 - 12/2018
3	Liposomes (Liposome)IBA 01/2022 - 12/2018
3	Lipid Bilayers (Lipid Bilayer)IBA 01/2022 - 11/2019
3	Silicon Dioxide (Silica)FDA LinkGeneric 03/2021 - 08/2017
3	p-coumaric acidIBA 03/2020 - 10/2019
2	FlavonoidsIBA 01/2022 - 12/2018
2	QuercetinIBA 01/2022 - 12/2018
2	Cytostatic AgentsIBA 01/2022 - 10/2016
2	SaltsIBA 10/2021 - 01/2020
2	CannabidiolIBA 10/2021 - 01/2020
2	Desoxycorticosterone Acetate (DOCA)FDA Link 10/2021 - 01/2020
2	ursodoxicoltaurineIBA 02/2021 - 11/2019
2	Coenzyme A (CoA)IBA 11/2019 - 10/2019
2	Histone Deacetylase InhibitorsIBA 10/2016 - 01/2016
1	PolyphenolsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	caffeic acidIBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2021
1	EndocannabinoidsIBA 10/2021
1	AcidsIBA 09/2020
1	ferulic acid (sodium ferulate)IBA 09/2020
1	cinnamic acidIBA 09/2020
1	capsazepineIBA 01/2020
1	(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)IBA 01/2020
1	L-161982IBA 01/2020
1	nimesulide (Aulin)IBA 01/2020
1	TRAM 34IBA 01/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	AM 251 (AM251)IBA 01/2020
1	iodopravadoline (AM 630)IBA 01/2020
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020
1	iberiotoxinIBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	ProstaglandinsIBA 01/2020
1	Cyclooxygenase InhibitorsIBA 01/2020
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2019
1	Taurine FDA Link 11/2019
1	SolutionsIBA 10/2019
1	ElectrolytesIBA 10/2019
1	Adenosine Triphosphatases (ATPase)IBA 08/2019
1	naphtho(1,2-d)thiazol-2-ylamineIBA 08/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 12/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	glucose-regulated proteinsIBA 01/2018
1	Caspase 9IBA 01/2018
1	belinostatIBA 10/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2016
1	Butyrates (Butyrate)IBA 01/2015
1	Butyric Acid (Butanoic Acid)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2018
1	Drug Therapy (Chemotherapy) 08/2019